EE05182B1 - Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon - Google Patents

Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon

Info

Publication number
EE05182B1
EE05182B1 EEP200200326A EEP200200326A EE05182B1 EE 05182 B1 EE05182 B1 EE 05182B1 EE P200200326 A EEP200200326 A EE P200200326A EE P200200326 A EEP200200326 A EE P200200326A EE 05182 B1 EE05182 B1 EE 05182B1
Authority
EE
Estonia
Prior art keywords
homopiperidobenzimidazole
analog
substituted
preparation
pharmaceutical composition
Prior art date
Application number
EEP200200326A
Other languages
English (en)
Estonian (et)
Inventor
Eduard Janssens Frans
Maria Sommen Fran�ois
Emile Georges Guillemont J�r�me
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200200326A publication Critical patent/EE200200326A/xx
Publication of EE05182B1 publication Critical patent/EE05182B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
EEP200200326A 1999-12-21 2000-12-14 Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon EE05182B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204441 1999-12-21
PCT/EP2000/012858 WO2001046189A1 (en) 1999-12-21 2000-12-14 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants

Publications (2)

Publication Number Publication Date
EE200200326A EE200200326A (et) 2003-10-15
EE05182B1 true EE05182B1 (et) 2009-06-15

Family

ID=8241040

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200326A EE05182B1 (et) 1999-12-21 2000-12-14 Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon

Country Status (33)

Country Link
US (1) US7304052B2 (cs)
EP (1) EP1250337B1 (cs)
JP (1) JP4852210B2 (cs)
KR (1) KR100715351B1 (cs)
CN (1) CN100343251C (cs)
AT (1) ATE416174T1 (cs)
AU (1) AU781144B2 (cs)
BG (1) BG65784B1 (cs)
BR (1) BRPI0016638B8 (cs)
CA (1) CA2393158C (cs)
CY (1) CY1108844T1 (cs)
CZ (1) CZ299803B6 (cs)
DE (1) DE60041001D1 (cs)
DK (1) DK1250337T3 (cs)
EA (1) EA005851B1 (cs)
EE (1) EE05182B1 (cs)
ES (1) ES2317856T3 (cs)
HK (1) HK1053109B (cs)
HR (1) HRP20020518B1 (cs)
HU (1) HU229929B1 (cs)
IL (2) IL150310A0 (cs)
MX (1) MXPA02006346A (cs)
MY (1) MY127758A (cs)
NO (1) NO322362B1 (cs)
NZ (1) NZ518816A (cs)
PL (1) PL199678B1 (cs)
PT (1) PT1250337E (cs)
SI (1) SI1250337T1 (cs)
SK (1) SK287113B6 (cs)
TW (1) TWI225488B (cs)
UA (1) UA73963C2 (cs)
WO (1) WO2001046189A1 (cs)
ZA (1) ZA200204983B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JP2005532991A (ja) 2002-01-10 2005-11-04 ニューロジェン・コーポレーション メラニン凝集ホルモン受容体リガンド：置換２−（４−ベンジル−ピペラジン−１−イルメチル）−及び２−（４−ベンジル−ジアゼパン−１−イルメチル）−１ｈ−ベンゾイミダゾールアナログ
AU2005214225B2 (en) * 2004-02-19 2010-05-20 Banyu Pharmaceutical Co., Ltd. Novel sulfone amide derivative
UA101149C2 (en) 2007-01-25 2013-03-11 Янссен Фармацевтика Нв 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
CN102958933B (zh) 2010-06-24 2016-02-03 吉里德科学公司 作为抗病毒药的吡唑并[1,5-a]嘧啶类
US20130303782A1 (en) * 2010-11-24 2013-11-14 Sequent Scientific Limited Process for preparation of albendazole
JP2014159375A (ja) * 2011-06-15 2014-09-04 Takeda Chem Ind Ltd アゼパン化合物
PT2794611T (pt) 2011-12-22 2017-12-06 Gilead Sciences Inc Pirazolo[1,5-a]pirimidinas como agentes antivirais
KR102181318B1 (ko) 2012-04-17 2020-11-20 길리애드 사이언시즈, 인코포레이티드 항바이러스 치료를 위한 화합물 및 방법
WO2015091584A1 (en) * 2013-12-18 2015-06-25 F. Hoffmann-La Roche Ag Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors
PL3720855T3 (pl) * 2017-12-08 2022-01-24 Boehringer Ingelheim International Gmbh Pochodne imidazopirydyny i ich zastosowanie jako leku

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060197C3 (de) * 1970-12-08 1979-02-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 2-Aminobenzothiazol und dessen N-Alkylsubstitutionsprodukten
US4093726A (en) 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
FR2528526A1 (fr) * 1982-06-09 1983-12-16 Sfr Sa Robinetterie Butee se fixant dans un alesage d'un dispositif
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE3634066A1 (de) * 1986-10-07 1988-04-21 Boehringer Mannheim Gmbh Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
JPH0260197A (ja) * 1988-08-26 1990-02-28 Nec Corp パッケージ構造
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv 10-(4-piperidinyl- and piperidinylidene)-imidazo [1,2-a] (pyrrolo thieno or furano) [2,3] azepine derivatives their preparation and pharmaceutical compositions containing them and certain novel intermediates therefor
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
PL307026A1 (en) * 1992-07-08 1995-05-02 Monsanto Co Method of producing ppaliative effect in respect to swine gastric ulcers
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
EP0711768B1 (en) * 1994-05-31 2002-02-13 Mitsui Chemicals, Inc. Benzimidazole derivative
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues

Also Published As

Publication number Publication date
UA73963C2 (uk) 2005-10-17
ATE416174T1 (de) 2008-12-15
CN1411460A (zh) 2003-04-16
EA200200700A1 (ru) 2003-06-26
CA2393158A1 (en) 2001-06-28
BR0016638B1 (pt) 2013-02-05
BG106749A (en) 2003-01-31
US20030139393A1 (en) 2003-07-24
US7304052B2 (en) 2007-12-04
MY127758A (en) 2006-12-29
NO322362B1 (no) 2006-09-25
WO2001046189A1 (en) 2001-06-28
MXPA02006346A (es) 2002-12-13
KR20020062643A (ko) 2002-07-26
BR0016638A (pt) 2002-10-01
SK287113B6 (sk) 2009-12-07
PT1250337E (pt) 2009-03-05
CZ20022055A3 (cs) 2003-06-18
EA005851B1 (ru) 2005-06-30
NO20022977D0 (no) 2002-06-20
ES2317856T3 (es) 2009-05-01
IL150310A0 (en) 2002-12-01
HRP20020518A2 (en) 2004-08-31
IL150310A (en) 2008-07-08
SI1250337T1 (sl) 2009-04-30
TWI225488B (en) 2004-12-21
HU229929B1 (en) 2015-01-28
NO20022977L (no) 2002-08-08
CY1108844T1 (el) 2014-07-02
CN100343251C (zh) 2007-10-17
BRPI0016638B8 (pt) 2017-04-25
JP4852210B2 (ja) 2012-01-11
AU781144B2 (en) 2005-05-05
KR100715351B1 (ko) 2007-05-08
NZ518816A (en) 2003-01-31
PL199678B1 (pl) 2008-10-31
JP2003518118A (ja) 2003-06-03
HUP0203847A2 (hu) 2003-03-28
HK1053109A1 (zh) 2003-10-10
HK1053109B (zh) 2008-08-01
CA2393158C (en) 2010-10-19
CZ299803B6 (cs) 2008-12-03
EP1250337B1 (en) 2008-12-03
SK8542002A3 (en) 2003-07-01
DE60041001D1 (de) 2009-01-15
DK1250337T3 (da) 2009-03-30
EE200200326A (et) 2003-10-15
EP1250337A1 (en) 2002-10-23
PL355442A1 (en) 2004-04-19
ZA200204983B (en) 2003-09-22
AU2167301A (en) 2001-07-03
HRP20020518B1 (en) 2009-02-28
HUP0203847A3 (en) 2004-07-28
BG65784B1 (bg) 2009-11-30

Similar Documents

Publication Publication Date Title
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
MXPA02011425A (es) Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa.
EA200100589A1 (ru) Азабициклоалканы как модуляторы ccr5
PL326203A1 (en) (methylsulphonyl)phenyl-2-(5)-furanones as cox-2 inhibitors
IL153406A0 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
BG106771A (en) Heterocyclic substituted pyrazolones
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
BRPI0412659A (pt) isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
EA200100203A1 (ru) Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ZA200203165B (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclo-oxygenase-2 and pharmaceutical compositions containing them.
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
SE9904129D0 (sv) Novel compounds
EE05182B1 (et) Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
EE200300488A (et) Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
SE9804212D0 (sv) Compounds
WO2005055943A3 (en) Vinorelbine derivatives
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
AU2002248531A1 (en) Pyrazolopyriadine derivatives

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20181214